Herpes zoster: risk categories for persistent pain

Area of Science:

• Virology and Immunology
• Clinical Medicine
• Epidemiology

Background:

• Herpes zoster (shingles) is characterized by acute neuritis and persistent pain, serving as critical clinical endpoints in therapeutic trials.
• Understanding patient subgroups at higher risk for prolonged symptoms is essential for optimizing treatment strategies.

Purpose of the Study:

• To identify patient subgroups at increased risk for persistent acute neuritis and zoster-associated pain following herpes zoster infection.
• To inform clinical decision-making regarding the intensity and timing of interventions based on presenting symptoms.

Main Methods:

• Analysis of patients in an acyclovir and prednisone study, categorized by pain severity and number of lesions at presentation.
• Utilized risk ratios (RRs) and Kaplan-Meier survival estimates to compare the rate of resolution for acute neuritis and zoster-associated pain.
• Defined risk categories based on the magnitude of risk ratios.

Main Results:

• Patients presenting with severe or incapacitating pain showed a significantly lower likelihood of symptom resolution (RR, 18.0; 95% CI, 6.6-48.6).
• A large number of lesions at presentation was also associated with a reduced chance of resolving both acute neuritis and zoster-associated pain (RR, 5.3; 95% CI, 4.2-17.2).
• These findings establish clear risk categories based on presenting clinical features.

Conclusions:

• Patients with severe pain and numerous lesions represent a high-risk subgroup for prolonged herpes zoster complications.
• The study strongly indicates the need for aggressive therapeutic interventions in these identified patient subgroups to improve clinical outcomes.
• Risk stratification based on initial presentation aids in tailoring patient management for herpes zoster.